Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

19.51 -0.38 (-1.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,223,540
Open 19.88
Bid (Size) 19.65 (5)
Ask (Size) 19.70 (2)
Prev. Close 19.89
Today's Range 19.50 - 20.08
52wk Range 9.350 - 25.67
Shares Outstanding 196,357,149
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ADMA BIOLOGICS INC (NASDAQ:ADMA) is not too expensive for the growth it is showing.
Discover ADMA BIOLOGICS INC, an undervalued growth gem. NASDAQ:ADMA is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing... 
Via Chartmill
Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings
Via Benzinga
Exposures Fossil Fuels

Performance

YTD
+8.6%
+8.6%
1 Month
-20.4%
-20.4%
3 Month
+25.7%
+25.7%
6 Month
-9.1%
-9.1%
1 Year
+105.2%
+105.2%

More News

Read More
Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits
Via Investor's Business Daily
Topics Earnings
Exposures Financial Product Safety
ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Earnings Scheduled For May 7, 2025
Via Benzinga
ADMA Biologics Earnings Preview
Via Benzinga
What's Driving the Market Sentiment Around ADMA Biologics?
Via Benzinga
3 Mid-Cap Medical Stocks Outperforming the Market
Via MarketBeat
Topics Economy
Exposures Economy
Should you consider ADMA BIOLOGICS INC (NASDAQ:ADMA) for growth investing?
Via Chartmill
Would Mark Minervini consider ADMA BIOLOGICS INC (NASDAQ:ADMA) a top stock pick?
Via Chartmill
ADMA Biologics Inc (NASDAQ:ADMA): A Strong Minervini Trend Template Candidate
Via Chartmill
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
What's Going On With ADMA Stock Monday?
Via Benzinga
Exposures Product Safety
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
From FN Media Group LLC
Via GlobeNewswire
Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday
Via Benzinga
IBD 50's Top Seed, ADMA, Just Rocketed On A New FDA Approval
Via Investor's Business Daily
Exposures Product Safety
ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
From ADMA Biologics, Inc.
Via GlobeNewswire
Why ADMA BIOLOGICS INC (NASDAQ:ADMA) qualifies as a high growth stock.
Via Chartmill
Investors seeking growth at a reasonable cost should explore ADMA BIOLOGICS INC (NASDAQ:ADMA).
Via Chartmill
ADMA Biologics Statement on Tariffs
From ADMA Biologics, Inc.
Via GlobeNewswire
What's Driving the Market Sentiment Around ADMA Biologics?
Via Benzinga
ADMA BIOLOGICS INC (NASDAQ:ADMA) is showing good growth, while it is not too expensive.
Via Chartmill
Adma Biologics' Retail Traders Eye Higher Open After Blowout Q4, Strong Full-Year Outlook
Via Stocktwits
ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is ADMA Biologics Inc - Common Stock publicly traded?
Yes, ADMA Biologics Inc - Common Stock is publicly traded.
What exchange does ADMA Biologics Inc - Common Stock trade on?
ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ADMA Biologics Inc - Common Stock?
The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market
What is the current price of ADMA Biologics Inc - Common Stock?
The current price of ADMA Biologics Inc - Common Stock is 19.51
When was ADMA Biologics Inc - Common Stock last traded?
The last trade of ADMA Biologics Inc - Common Stock was at 05/28/25 04:00 PM ET
What is the market capitalization of ADMA Biologics Inc - Common Stock?
The market capitalization of ADMA Biologics Inc - Common Stock is 3.83B
How many shares of ADMA Biologics Inc - Common Stock are outstanding?
ADMA Biologics Inc - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.